Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Poosanu Thanapornsangsuth"'
Autor:
Wanakorn Rattanawong MD, Tatchaporn Ongphichetmetha MD, Thiravat Hemachudha MD, Poosanu Thanapornsangsuth MD
Publikováno v:
Journal of Central Nervous System Disease, Vol 15 (2023)
Background Ischemic stroke is a leading cause of morbidity and mortality worldwide. One possible predictor is the use of biomarkers especially neurofilament light chain (NFL). Objectives To explore whether NFL could predict clinical outcome and hemor
Externí odkaz:
https://doaj.org/article/db2ba2b579804a289c4fe9ff84761807
Autor:
Thanakit Pongpitakmetha, Pasin Hemachudha, Wanakorn Rattanawong, Poosanu Thanapornsangsuth, Anand Viswanathan, Thiravat Hemachudha
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background We report the first case of COVID-19 associated acute necrotizing encephalopathy (ANE) without pulmonary disease in a patient with an extremely high interleukin-6 (IL-6) level and Ran Binding Protein 2 (RANBP2) mutation. Case pres
Externí odkaz:
https://doaj.org/article/0b2d62a9484143fe922cb761dff3b65c
Autor:
Poosanu Thanapornsangsuth, Adipa Chongsuksantikul, Abhinbhen W. Saraya, Akarin Hiransuthikul, Thiravat Hemachudha
Publikováno v:
Journal of Neurochemistry.
Autor:
Poosanu Thanapornsangsuth, Kittithatch Booncharoen, Watayuth Luechaipanit, Thirawat Supharatpariyakorn, Yuthachai Sarutikriangkri, Suchart Tangnimitchok, Yuttachai Likitjaroen, Chanan Sukprakun, Supatporn Tepmongkol, Thiravat Hemachudha
Publikováno v:
Alzheimer's & Dementia.
Autor:
Tatchaporn Ongphichetmetha, Poosanu Thanapornsangsuth, Watayuth Luechaipanit, Nattawan Loymunkong, Wanakorn Rattanawong, Akarin Hiransuthikul, Thirawat Supharatpariyakorn, Sira Sriswasdi, Thiravat Hemachudha
Publikováno v:
Brain Communications; 2023, Vol. 5 Issue 6, p1-8, 8p
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Poosanu Thanapornsangsuth, Tatchaporn Ongphichetmetha, Watayuth Luechaipanit, Pasin Hemachudha, Thiravat Hemachudha
Publikováno v:
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 14
Phosphorylated tau (p-tau)181 has become a promising blood-based Alzheimer's disease (AD) biomarker. We studied the agreement of plasma p-tau181 and cerebrospinal fluid (CSF) markers in patients with alteration of consciousness (AOC).Plasma and CSF w
Autor:
Yuttachai Likitjaroen, Kammant Phanthumchinda, Poosanu Thanapornsangsuth, Anthipa Chokesuwattanaskul
Publikováno v:
Alzheimer's & Dementia. 16